Yuqi Yang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 12
- Extracellular vesicles in disease 12
- Oncology 50
- Drug Transport and Resistance Mechanisms 35
- Co-authors
- Zhe‐Sheng Chen (43 shared papers)Jing‐Quan Wang (35 shared papers)Kelong Ai (21 shared papers)Qiong Huang (22 shared papers)Liang Cheng (28 shared papers)Zuoxiu Xiao (18 shared papers)Qiaohui Chen (20 shared papers)Zhuo‐Xun Wu (25 shared papers)
- Journals
- Frontiers in Pharmacology (11 papers)Frontiers in Oncology (11 papers)Journal of Investigative Dermatology (7 papers)Advanced Science (6 papers)ACS Nano (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yuqi Yang
225 papers receiving 6.1k citations
Yuqi Yang's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 896
- Oncology 1.2k
- Biomaterials 535
- Molecular Biology 2.5k
- Biomedical Engineering 1.5k
Countries citing papers authored by Yuqi Yang
This map shows the geographic impact of Yuqi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqi Yang more than expected).
Fields of papers citing papers by Yuqi Yang
This network shows the impact of papers produced by Yuqi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqi Yang. The network helps show where Yuqi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuqi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy Hit paper breakdown → | 2022 | 180 |
| 2 | 2021 | 173 | |
| 3 | Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance Hit paper breakdown → | 2021 | 171 |
| 4 | 2022 | 155 | |
| 5 | 2016 | 148 | |
| 6 | 2019 | 125 | |
| 7 | 2022 | 122 | |
| 8 | 2021 | 112 | |
| 9 | 2023 | 109 | |
| 10 | 2015 | 106 | |
| 11 | 2021 | 105 | |
| 12 | 2022 | 99 | |
| 13 | 2022 | 98 | |
| 14 | 2020 | 93 | |
| 15 | 2022 | 93 | |
| 16 | 2022 | 92 | |
| 17 | 2018 | 91 | |
| 18 | 2022 | 89 | |
| 19 | 2017 | 85 | |
| 20 | Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response Hit paper breakdown → | 2024 | 83 |
About Yuqi Yang
Yuqi Yang is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Immunology and Materials Chemistry, having authored 240 papers that have together received 6.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (38 papers), Drug Transport and Resistance Mechanisms (35 papers), melanin and skin pigmentation (13 papers), Advanced Nanomaterials in Catalysis (13 papers), HIV/AIDS drug development and treatment (12 papers), Cancer therapeutics and mechanisms (12 papers), Extracellular vesicles in disease (12 papers) and Pharmacological Effects and Toxicity Studies (9 papers). The work is most often cited by research in Cancer Research (896 citations), Oncology (1.2k citations), Biomaterials (535 citations), Molecular Biology (2.5k citations) and Biomedical Engineering (1.5k citations). Yuqi Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhe‐Sheng Chen, Jing‐Quan Wang, Kelong Ai, Qiong Huang, Liang Cheng, Zuoxiu Xiao, Qiaohui Chen, Zhuo‐Xun Wu, Qiu‐Xu Teng and Chunying Li. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Oncology, Journal of Investigative Dermatology, Advanced Science and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.